Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep;42(9):2829-2840.
doi: 10.1007/s10792-022-02273-x. Epub 2022 Apr 2.

Surgical management of glaucoma following different keratoplasty techniques

Affiliations

Surgical management of glaucoma following different keratoplasty techniques

Ozum Oztutuncu et al. Int Ophthalmol. 2022 Sep.

Abstract

Purpose: To investigate the results of surgical management of glaucoma following different keratoplasty techniques.

Methods: Medical records of 628 cases who underwent keratoplasty were reviewed. One hundred and eighty-eight patients (29.9%) who developed post-keratoplasty glaucoma were evaluated. Patients who could not be controlled with maximal medical treatment and underwent glaucoma surgery were included in this study. Trabeculectomy, Ahmed glaucoma valve (AGV) implantation or diode laser cyclophotocoagulation (DLC) were applied.

Results: Glaucoma surgery was performed in 55 (29.3%) patients who had uncontrolled post-keratoplasty glaucoma. In penetrating keratoplasty group (n = 42), DLC was applied to 30 (71.4%) eyes, AGV to 11 (26.2%) eyes, and trabeculectomy in 1 (2.4%) eye. In Descemet's membrane endothelial keratoplasty group (n = 8), DLC was applied to 4 (50%) eyes, trabeculectomy for 3 (37.5%) eyes and AGV for 1 (12.5%) eye. In deep anterior lamellar keratoplasty group (n = 5), DLC was applied to 2 (40%) eyes, trabeculectomy to 2 (40%) eyes and AGV to 1 (20%) eye. While a statistically significant decrease was found in intraocular pressure (IOP) and anti-glaucomatous medication after surgery (p < 0.05 for each), no significant difference was found in best corrected visual acuity (BCVA). During follow-up, DLC was applied as re-glaucoma surgery in 19 (34.5%) cases. A significant reduction in IOP together with number of anti-glaucomatous medications was found with re-operation; however, a significant decrease in BCVA was noted (p < 0.05 for each).

Conclusion: Glaucoma surgeries after keratoplasty are effective in decreasing IOP and the number of anti-glaucomatous medication. While BCVA doesn't change after the first glaucoma surgery, after re-operation significant decrease may occur.

Keywords: Deep anterior lamellar keratoplasty; Descemet’s membrane endothelial keratoplasty; Glaucoma surgery; Penetrating keratoplasty.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Yildirim N, Gursoy H, Sahin A (2011) Glaucoma after penetrating keratoplasty: incidence, risk factors, and management. J Ophthalmol 2011:951294 - PubMed - PMC
    1. Zemba M, Stamate AC (2017) Glaucoma after penetrating keratoplasty. Roman J Opthalmol 61:159–165
    1. Ayyala RS (2000) Penetrating keratoplasty and glaucoma. Surv Ophthalmol 45:91–105 - PubMed
    1. Kornmann HL, Gedde SJ (2016) Glaucoma management after corneal transplantation surgeries. Curr Opin Ophthalmol 27:132–139 - PubMed - PMC
    1. França ET, Arcieri ES, Arcieri RS (2002) A study of glaucoma after penetrating keratoplasty. Cornea 21:284–288 - PubMed

LinkOut - more resources